Abstract: A medical imaging device connector assembly for connecting a medical imaging device to a terminal of a medical imaging system is provided. The medical imaging device connector assembly includes a top housing having a first base cutout; a bottom housing configured to couple to the top housing, the bottom housing including a second base cutout; a base housing positioned within the first and second base cutouts; a plurality of printed circuit boards (PCBs) disposed between the top housing and the bottom housing; an electrical connector positioned within the base housing; and an elastic seal member surrounding a circumference of the base housing. When the top housing is coupled to the bottom housing, the elastic seal member is compressed by the plurality of PCBs in a first direction and by the top and bottom housings in a second direction perpendicular to the first direction to prevent fluid ingress.

Abstract: The embodiments herein provide a method and a system for generating and regulating local magnetic field variations required for spin qubit manipulation based on scalable quantum processors using micro-structures in integrated circuits. In an embodiment the system provides an adaptive and independent magnetic-field control to each qubit on a hardware substrate and comprises several micro/nano-scale current-carrying structures near a qubit for controlling and manipulating the qubit using the locally generated variable magnetic field, in-turn controlled by the tunable current flowing through these structures. The current-carrying structures in conjunction with fast current control provides fast switching/tuning of magnetic fields for rapid adiabatic passage control of one or more qubits simultaneously.

Abstract: The present invention pertains to an ophthalmic composition of Bevacizumab, in a single use prefilled syringe which is safe, non-toxic and efficacious for administration during the shelf life, characterised in that the ophthalmic solution is controlled with respect to the number of sub-visible particulate matter with significantly reduced endotoxin levels and with low aggregate level that are suitable for intravitreal use during the shelf life of 2 years of the product.

Abstract: An approach for updating one or more serverless runtime configurations based on predicting usage patterns of a serverless computing cluster is disclosed. The approach includes collecting one or more attributes associated with an application on a serverless computing cluster and a user of the application and analyzing the one or more collected attributes. Furthermore, the approach includes predicting one or more usage patterns based the analyzing and updating one or more serverless runtime configurations based on the one or more usage patterns.

Abstract: A system for cooling a heat generating component of a vehicle. The system includes a blower of a vehicle heating, ventilation, and air conditioning (HVAC) system. An air duct extends from the blower to the heat generating component to cool the heat generating component.

Abstract: A neural network control system and method includes vehicle sensors in communication with a neural network controller in a vehicle. The neural network (NN) operates in at least two modes: a training mode and a control mode. The NN consists of at least computational five layers the layers containing a plurality of neurons. Sensor data is received by an NN controller and processed through the layers where each of the neurons applies a weight to the sensor data. In the training mode the weights are continuously adjusted until a threshold difference between a known reference signal and a plant output is achieved. In the control mode, the NN controller continuously and recursively sends a control signal commanding the plant to adjust an actuator position in response to the sensor data until a disturbance in the sensor data is substantially eliminated.

Abstract: A computer-implemented method of data protection for containerized applications includes initiating a backup process for a containerized application comprising an application template, application information, and application data. An application template associated with the application is saved to a first repository. Application information is identified and saved to a second repository. A persistent volume containing the application data is identified and at least some of the application data from the persistent volume is saved to a third repository. The application is then restored based on the saved template, application information and application data.

Abstract: The present invention relates to a novel, economically viable, storage stable, lyophilized composition of pegaspargase. The composition comprises pegaspargase, a cryoprotectant, a bulking agent, a buffer and may optionally contain other pharmaceutically acceptable excipients including but not limited to a salt. The composition of the present invention is stable for extended periods over significant range of temperatures, without the presence of any significant amount of impurities. The present invention also relates to an economically viable and scalable lyophilization process for the production of the storage stable composition of pegaspargase.

Abstract: A system for cooling a heat generating component of a vehicle. The system includes a blower of a vehicle heating, ventilation, and air conditioning (HVAC) system. An air duct extends from the blower to the heat generating component to cool the heat generating component.

Abstract: The present invention pertains to an economic packed-bed perfusion system for the production of pharmaceutical grade of recombinant TNK-tPA. The present invention involves a cell culture process utilizing CHO cells more specifically in a micro/macro carriers based packed-bed perfusion system. The process of the present invention results in optimum cell growth and maintenance, and minimal build-up of toxic by-products such as lactate and ammonia. The system of the present invention discloses optimized process parameters to enable a resultant TNK-tPA with high yield and pharmaceutical grade purity. The process of the present invention is industrially applicable and possesses economy of scale.

Abstract: A computer-implemented method of data protection for containerized applications includes initiating a backup process for a containerized application comprising an application template, application information, and application data. An application template associated with the application is saved to a first repository. Application information is identified and saved to a second repository. A persistent volume containing the application data is identified and at least some of the application data from the persistent volume is saved to a third repository. The application is then restored based on the saved template, application information and application data.

Abstract: A computer-implemented method of data protection for containerized applications includes initiating a backup process for a containerized application comprising an application template, application information, and application data. An application template associated with the application is saved to a first repository. Application information is identified and saved to a second repository. A persistent volume containing the application data is identified and at least some of the application data from the persistent volume is saved to a third repository. The application is then restored based on the saved template, application information and application data.

Abstract: Non-limiting examples of the present disclosure describe electronic document generation, where an electronic document of an application/service may be dynamically generated in a manner that is tailored specifically for a user. A query may be received that comprises a topic for generation of a slide-based visual presentation. The query is processed. In some examples, slide content suggestions may be generated and presented to a user based on the query processing. Content for a processed query may be retrieved by a plurality of data service providers that are connected with the visual presentation service via a distributed network. An electronic document may be generated for the slide-based visual presentation. The electronic document is specifically tailored for a user and dynamically generated based on one or more of: the processing of the query, the retrieved content, a selection of one or more slide content suggestions and an evaluation of signal data associated with the user.

Abstract: A medical imaging device connector assembly for connecting a medical imaging device to a terminal of a medical imaging system is provided. The medical imaging device connector assembly includes a top housing having a first base cutout; a bottom housing configured to couple to the top housing, the bottom housing including a second base cutout; a base housing positioned within the first and second base cutouts; a plurality of printed circuit boards (PCBs) disposed between the top housing and the bottom housing; an electrical connector positioned within the base housing; and an elastic seal member surrounding a circumference of the base housing. When the top housing is coupled to the bottom housing, the elastic seal member is compressed by the plurality of PCBs in a first direction and by the top and bottom housings in a second direction perpendicular to the first direction to prevent fluid ingress.

Abstract: The vagus nerve and branches of the vagus nerve are stimulated below the laryngeal nerve branch bifurcation in order to induce desired parasympathetic responses, such as decreased heart rate, without also triggering any adverse sympathetic responses. Stimulating surfaces of an open field bipolar electrode are positioned on or inserted through the pleural membrane overlying the vagus nerve at a location having substantially no cardiac sympathetic fibers adjacent to the vagus nerve. The open field bipolar electrodes can be securable-wire, needle, plate, or any other type of electrode suitable for being secured to the pleural membrane using one or more fastening mechanisms. Electrical stimuli are generated by a stimulator connected to the stimulating surfaces of the open field bipolar electrode by one or more leads.

Abstract: The vagus nerve and branches of the vagus nerve are stimulated below the laryngeal nerve branch bifurcation in order to induce desired parasympathetic responses, such as decreased heart rate, without also triggering any adverse sympathetic responses. Stimulating surfaces of an open field bipolar electrode are positioned on or inserted through the pleural membrane overlying the vagus nerve at a location having substantially no cardiac sympathetic fibers adjacent to the vagus nerve. The open field bipolar electrodes can be securable-wire, needle, plate, or any other type of electrode suitable for being secured to the pleural membrane using one or more fastening mechanisms. Electrical stimuli are generated by a stimulator connected to the stimulating surfaces of the open field bipolar electrode by one or more leads.

Abstract: The present invention relates to a novel process of isolating and purifying tissue plasminogen activator and its variants more specifically TNK-tPA from CHO cells and describes an industrially applicable, simple, cost effective, robust and highly efficient process of TNK-tPA purification.

Abstract: The present invention provides a novel, scalable and industrially viable downstream process for purification of recombinant human G-CSF.

Abstract: Systems, methods, and apparatuses for detecting fluid ingress in ultrasound probes are disclosed. A fluid ingress may be detected by a change in resistance, capacitance, and/or current of a fluid ingress detector of a fluid ingress detection assembly. A fluid ingress detector that includes a soluble material is disclosed. A fluid ingress detector that includes a galvanic sensor is disclosed. The fluid ingress detector may provide a signal indicating a fluid ingress to an ultrasound imaging system and/or a maintenance diagnostic system.

Abstract: The present invention relates to a novel process of isolating and purifying tissue plasminogen activator and its variants more specifically TNK-tPA from CHO cells and describes an industrially applicable, simple, cost effective, robust and highly efficient process of TNK-tPA purification.